Evidence map›Paper›PMID 35110523›Full record

ArticleSignal transduction and targeted therapy2022

sRAGE alleviates SARS-CoV-2-induced pneumonia in hamster.

Xiuqin Zhang, Dan Li, Rui Sun, Xinli Hu, Zhiqi Song, Xiaotian Ni, Hua Zhu, Tiannan Guo, Chuan Qin, Rui-Ping Xiao

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Signal transduction and targeted therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xiuqin Zhang *Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Dan Li *Key Laboratory of Human Disease Comparative Medicine of National Health Commission of the People's Republic of China, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
Rui Sun *Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China.
Xinli Hu *Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID 0000-0003-4911-5354
Zhiqi Song *Key Laboratory of Human Disease Comparative Medicine of National Health Commission of the People's Republic of China, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
Xiaotian NiInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Hua ZhuKey Laboratory of Human Disease Comparative Medicine of National Health Commission of the People's Republic of China, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China.
Tiannan GuoWestlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, China. guotiannan@westlake.edu.cn.ORCID 0000-0003-3869-7651
Chuan QinKey Laboratory of Human Disease Comparative Medicine of National Health Commission of the People's Republic of China, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China. qinchuan@pumc.edu.cn.ORCID 0000-0002-6261-1232
Rui-Ping XiaoInstitute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China. xiaor@pku.edu.cn.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking University · CNWestlake University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntiviral AgentsCombined Modality TherapyCOVID-19CricetinaeDisease Models, AnimalGene Expression RegulationHumansLungPneumoniaReceptor for Advanced Glycation End ProductsSARS-CoV-2AGER protein, humanAntiviral AgentsReceptor for Advanced Glycation End Products

Identifiers

PMID35110523
PMCPMC8809059
OpenAlexW4210617595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.